Chen, P.; Zhang, X.; Venosa, A.; Lee, I.H.; Myers, D.; Holloway, J.A.; Prud’homme, R.K.; Gao, D.; Szekely, Z.; Laskin, J.D.;
et al. A Novel Bivalent Mannosylated Targeting Ligand Displayed on Nanoparticles Selectively Targets Anti-Inflammatory M2 Macrophages. Pharmaceutics 2020, 12, 243.
https://doi.org/10.3390/pharmaceutics12030243
AMA Style
Chen P, Zhang X, Venosa A, Lee IH, Myers D, Holloway JA, Prud’homme RK, Gao D, Szekely Z, Laskin JD,
et al. A Novel Bivalent Mannosylated Targeting Ligand Displayed on Nanoparticles Selectively Targets Anti-Inflammatory M2 Macrophages. Pharmaceutics. 2020; 12(3):243.
https://doi.org/10.3390/pharmaceutics12030243
Chicago/Turabian Style
Chen, Peiming, Xiaoping Zhang, Alessandro Venosa, In Heon Lee, Daniel Myers, Jennifer A. Holloway, Robert K. Prud’homme, Dayuan Gao, Zoltan Szekely, Jeffery D. Laskin,
and et al. 2020. "A Novel Bivalent Mannosylated Targeting Ligand Displayed on Nanoparticles Selectively Targets Anti-Inflammatory M2 Macrophages" Pharmaceutics 12, no. 3: 243.
https://doi.org/10.3390/pharmaceutics12030243
APA Style
Chen, P., Zhang, X., Venosa, A., Lee, I. H., Myers, D., Holloway, J. A., Prud’homme, R. K., Gao, D., Szekely, Z., Laskin, J. D., Laskin, D. L., & Sinko, P. J.
(2020). A Novel Bivalent Mannosylated Targeting Ligand Displayed on Nanoparticles Selectively Targets Anti-Inflammatory M2 Macrophages. Pharmaceutics, 12(3), 243.
https://doi.org/10.3390/pharmaceutics12030243
